Disabling or fatal stroke rate within and beyond 30 days in the SAMMPRIS study.

Note:

# The disabling or fatal stroke rates within 30 days could be found in Table 3 in reference 8.

* The disabling or fatal stroke rates at the end of 32.4 months of follow-up for both groups could be found in Table 3 in reference 9.

** The number of patients with disabling or fatal stroke beyond 30 days was 21–16 = 5 for the PTAS group but 18–4 = 14 for the MED group, whereas the number of patients who finished the follow-up was 191 for the PTAS group and 210 for the MED group (see the Results of reference 9). PTAS: percutaneous transluminal angioplasty and stenting; MED: medical management group.

Disabling or fatal stroke rate within and beyond 30 days in the SAMMPRIS study.